Oral administration of shark type II collagen suppresses complete Freund's adjuvant-induced rheumatoid arthritis in rats

Pharmaceuticals

Volumn 5, Issue 4, 2012, Pages 339-352

  Chen, Lijuan ^a   Bao, Bin ^a   Wang, Nanping ^b   Xie, Jing ^a   Wu, Wenhui ^a  

^a SHANGHAI OCEAN UNIVERSITY   (China)

^b Shanghai Testing and Supervising Station on Aquatic Products Quality   (China)

Author keywords

Oral tolerance; Rheumatoid arthritis; Shark type II collagen

Indexed keywords

ACETIC ACID; COLLAGEN; COLLAGEN TYPE 2; FAS ANTIGEN; FREUND ADJUVANT; INTERLEUKIN 10; PLANT GLYCOSIDE; POLYGLYCOSIDIUM; RECOMBINANT PROTEIN; SHARK TYPE II COLLAGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG TARGETING; DRUG TOLERABILITY; EXPERIMENTAL RAT; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; JOINT SWELLING; MALE; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PEPTIDE MAPPING; PROTEIN BLOOD LEVEL; RAT; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 84860266882     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph5040339     Document Type: Article

References (31)

1. Lydyard, P.M.; Whelan, A.; Fanger, M.W. Immunology; Science Press: Beijing, China, 2009; Section L, p. 215.
2. Borchers, A.T.; Keen, C.L.; Cheema, G.S.; Gershwin, M.E. The use of methotrexate in rheumatoid arthritis. Semin. Arthritis Rheum. 2004, 1, 465-483.
3. Caporali, R.; Caprioli, M.; Bobbi-Pallavicini, F.; Montecucco, C. DMARDS and infections in rheumatoid arthritis. Autoimmun. Rev. 2008, 8, 139-143.
4. Iván, A.F.; Machín, S.; Carmona, L.; Isidoro, G.A.; Federico, D.G. Pattern of use and safety of non-steroidal anti-inflammatory drugs in rheumatoid arthritis patients. A prospective analysis from clinical practice. Reumatol. Clin. 2009, 6, 252-258.
5. Cremer, M. Type II Collagen-induced Arthritis in Rats. In Handbook of Animal Models for the Rheumatic Diseases; Greenwald, R.A., Diamond, H.S., Eds.; CRC Press: Boca Raton, FL, USA, 1988; pp. 17-27.
6. Banerjee, S.; Wei, B.Y.; Hillman, K.; Luthra, H.S.; David, C.S. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J. Immunol. 1988, 141, 1150-1154.
7. Strobel, S.; Mowat, A.M. Immune responses to dietary antigens: oral tolerance. Immunol. Today 1998, 19, 173-181.
8. Weiner, H.L. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol. Today 1997, 18, 335-343.
9. Thompson, S.J.; Thompson, H.S.; Harper, N.; Day, M.J.; Coad, A.J.; Elson, C.J.; Staines, N.A. Prevention of pristine-induced arthritis by the oral administration of type II collagen. Immunology 1993, 79, 152-157.
10. Khare, S.D.; Krco, C.J.; Griffiths, M.M.; Luthra, H.S.; David, C.S. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J. Immunol. 1995, 155, 3653-3659.
11. Meyer, O. L'immunomodulation par voie orale dans la polyarthrite. Rev. Rhum. 2000, 67, 593-603.
12. Zhao, W.; Tong, T.; Wang, L.; Li, P.P.; Chang, Y.; Zhang, L.L.; Wei, W. Chicken type II collagen induced immune tolerance of mesenteric lymph node lymphocytes by enhancing beta2-adrenergic receptor desensitization in rats with collagen-induced arthritis. Int. Immunopharmacol. 2011, 11, 12-18.
13. Trentham, D.E.; Dynesius-Trentham, R.A.; Orav, E.J.; Combitchi, D.; Lorenzo, C.; Sewell, K.L.; Hafler, D.A. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993, 261, 1727-1730.
14. Barnett, M.L.; Kremer, J.M.; William, E.; Clegg, D.O.; Furst, D.; Weisman, M. Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 1998, 290-297.
15. Poole, A.R. Cartilage in Health and Disease. In Arthritis and Allied Conditions: A Textbook of Rheumatology, 15th ed.; Koopman, W.J., Moreland, L.W., Eds.; Williams and Wilkins: Baltimore, MD, USA, 2005; pp. 223-269.
16. Nomura, Y. Properties and Utilization of Shark Collagen. In More Efficient Utilization of Fish and Fisheries Products; Elsevier: New York, NY, USA, 2004; Volume 42, pp. 147-158.
17. Kittiphattanabawon, P.; Benjakul, S.; Visessanguan, W.; Nagai, T.; Tanaka, M. Characterisation of acid-soluble collagen from skin and bone of bigeye snapper (Priacanthus tayenus). Food Chem. 2005, 89, 363-372.
18. Nalinanon, S.; Benjakul, S.; Visessanguan, W.; Kishimura, H. Tuna pepsin: Characteristics and its use for collagen extraction from the skin of threadfin bream (Nemipterus spp.). J. Food Sci. 2008, 73, C413-C419.
19. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 277, 680-685.
20. Pincus, T.; Marcum, S.B.; Callahan, L.F. Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J. Rheumatol. 1992, 19, 1885-1894.
21. Newbould, B.B. Chemotherapy of arthritis induced in rats by mycobacterium adjuvant. Br. J. Pharmacol. 1963, 21, 127-136.
22. Omura, K.; Imai, S.; Maeda, T.; Hukuda, S. Prolonged and increasing expression of Fos related antigens in the hippocampus of adjuvant arthritic rats. J. Rheumatol. 1998, 25, 936-944.
23. Hughes, C.; Wolos, J.A.; Giannini, E.H.; Hirsch, R. Induction of T helper cell hyporesponsiveness in an experimental model of autoimmunity by using nonmitogenic anti-CD3 monoclonal antibody. J. Immunol. 1994, 153, 3319-3325.
24. Banerjee, S.; Wei, B.Y.; Hillman, K.; Luthra, H.S.; David, C.S. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J. Immunol. 1988, 141, 1150-1154.
25. Thorbecke, G.J.; Schwarcz, R.; Leu, J.; Huang, C.; Simmons, W.J. Modulation by cytokines of induction of oral tolerance to type II collagen. Arthritis Rheum. 1999, 42, 110-118.
26. Zhu, P.; Li, X.Y.; Wang, H.K.; Jia, J.F.; Zheng, Z.H.; Ding, J.; Fan, C.M. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Clin. Immunol. 2007, 122, 75-84.
27. Garcia, G.; Komagata, Y.; Slavin, A.J.; Maron, R.; Weiner, H.L. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen. J. Autoimmun. 1999, 13, 315-324.
28. Weiner, H.L. Oral tolerance, an active immunologic process mediated by multiple mechanisms. J. Clin. Invest. 2000, 106, 935-937.
29. Illum, L.; Farraj, N.F.; Davis, S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 1994, 11, 1186-1189.
30. Hall, G.; Lund, L.; Lamb, J.R.; Jarman, E.R. Kinetics and mode of peptide delivery via the respiratory mucosa determine the outcome of activation versus TH2 immunity in allergic inflammation of the airways. J. Allergy Clin. Immunol. 2002, 110, 883-890.
31. Toussirot, E.A. Oral tolerance in the treatment of rheumatoid arthritis. Curr. Drug Targets 2002, 1, 45-52.